Q1 2024 Neurocrine Biosciences Inc Earnings Call
Neurocrine Biosciences Reports Robust Financial Performance and Pipeline Progress
Neurocrine stock rose Wednesday after the leading biotech topped Wall Street's sales expectations and wrapped a key regulatory filing.